Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma and Other Malignant Neoplasms of Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03313492
What this trial is testing

Modifying Young Adult Skin Cancer Risk and Protective Behaviors

Who this might be right for
Melanoma and Other Malignant Neoplasms of Skin
Rutgers, The State University of New Jersey 1,746
Early research (Phase 1)Active Not RecruitingNCT05538130
What this trial is testing

Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Who this might be right for
MelanomaGliomaThyroid Cancer+10 more
Pfizer 148
Early research (Phase 1)Study completedNCT02791334
What this trial is testing

Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

Who this might be right for
Solid TumorMicrosatellite Instability-High (MSI-H) Solid TumorsCutaneous Melanoma+2 more
Eli Lilly and Company 164
Testing effectiveness (Phase 2)Looking for participantsNCT07115043
What this trial is testing

Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more
AstraZeneca 120
Testing effectiveness (Phase 2)Study completedNCT02819843
What this trial is testing

T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors

Who this might be right for
MelanomaMerkel Cell CarcinomaOther Solid Tumors
Memorial Sloan Kettering Cancer Center 19
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06090266
What this trial is testing

OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Who this might be right for
CancerTumor, SolidMalignant Neoplasm+4 more
OncoResponse, Inc. 168
Early research (Phase 1)Looking for participantsNCT03093909
What this trial is testing

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Who this might be right for
Malignant Neoplasm of Bone and Articular CartilageMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Independent (Primary) Multiple Sites+7 more
M.D. Anderson Cancer Center 44
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00003750
What this trial is testing

Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors

Who this might be right for
Melanoma (Skin)NeuroblastomaSarcoma+1 more
Children's Oncology Group 28
Testing effectiveness (Phase 2)Ended earlyNCT04985604
What this trial is testing

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorCRAF Gene Amplification+20 more
Day One Biopharmaceuticals, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00074308
What this trial is testing

Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers

Who this might be right for
Recurrent MelanomaStage III MelanomaStage IV Melanoma+1 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT02857270
What this trial is testing

LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic MelanomaMetastatic Non-small Cell Lung Cancer+1 more
Eli Lilly and Company 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Ended earlyNCT03684785
What this trial is testing

Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Merkel Cell CarcinomaAdvanced or Metastatic Cutaneous Squamous Cell CarcinomaAdvanced or Metastatic Melanoma+2 more
Exicure, Inc. 57
Early research (Phase 1)Study completedNCT02475213
What this trial is testing

Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer

Who this might be right for
MelanomaHead and Neck CancerNon Small Cell Lung Cancer+1 more
MacroGenics 146
Early research (Phase 1)Study completedNCT01239134
What this trial is testing

Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors

Who this might be right for
Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies
Leap Therapeutics, Inc. 10
Early research (Phase 1)Study completedNCT00004016
What this trial is testing

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
University of Rochester
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT03864042
What this trial is testing

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Melanoma
Pfizer 56
Next Page